Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: Argus research - You Need To See This

ADBE Stock Warning: Why This Analyst Just Cut His Price Target on Adobe

Citi analyst recently lowered Adobe’s price target, reflecting a shifting market sentiment toward the stock.

Barchart

Broadcom To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Amazon To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Take-Two Interactive Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Nvidia To Rally More Than 37%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

SMCI Stock Alert: Super Micro Just Waved Another Red Flag

Supermicro stock slips on renewed concerns about financial reporting controls. Here’s why you shouldn’t buy the dip in SMCI shares today.

Barchart

Read news from The Economist, FT, and more,
with one subscription

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

Wall Street gives these three diverse names Strong Buy recommendations with high potential upside.

Kiplinger

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Reddit CEO Steve Huffman Is Selling RDDT Stock. Should You?

Reddit insiders have been selling company shares in August. But Argus Research recommends sticking with RDDT stock for the longer term.

Barchart

Micron To Rally More Than 49%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

2 Reasons to Sell Tesla Stock in June 2025

Two Tesla stock downgrades have some investors reeling about holding shares long-term.

Barchart

Tesla Stock: Why These 2 Downgrades Are Actually a Buy Signal

Tesla shares are climbing despite dual downgrades, creating a rare entry opportunity for investors who believe in their long-term potential.

MarketBeat

Alibaba Stock Gains on Promises Its New AI Model Is Better Than DeepSeek

Alibaba stock is higher Wednesday after the Chinese conglomerate said its updated AI model outperforms DeepSeek and other competitors. Here's what to know.

Kiplinger

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.

Kiplinger

Qorvo Stock Pops After Starboard Takes a Stake in the Apple Supplier: What to Know

Qorvo stock is soaring Friday after activist investor Starboard Value disclosed a new stake in the Apple supplier. Here's what investors need to know.

Kiplinger

Moderna Stock Is Volatile Amid Bird Flu Developments

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.

Barchart

Stocks See Support on the Last Trading Day of the Year

The S&P 500 Index ($SPX ) (SPY ) today is up +0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.05%. March E-mini S&P futures (ESH25 ) are up +0.21%, and March E-mini Nasdaq futures...

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

What's in Store for the Bull Market in 2025?

The current bull market recently turned two and most – but not all – Wall Street pros expect the party to continue in the new year.

Kiplinger

Honeywell Is the Best Dow Stock on Spinoff Speculation

Honeywell stock is higher Monday on news the industrial giant may spin off its aerospace segment. Here's what you need to know.

Kiplinger

What's Behind Ford Stock's New Sell Rating?

Jefferies downgraded Ford on concerns over earnings headwinds and "challenging decisions ahead." Here's what investors need to know.

Kiplinger

UnitedHealth Stock Falls as Lawmakers Eye Insurers, PBMs

UnitedHealth stock is continuing to fall Thursday after the introduction of bipartisan legislation targeting PBMs and healthcare giants. Here's what to know.

Kiplinger

What's at Stake for Alphabet as DOJ Eyes Google's Chrome

Alphabet is higher Tuesday even as antitrust officials at the DOJ support forcing Google to sell its popular web browser. Here's what you need to know.

Kiplinger

Lowe's Stock Is Falling After Earnings. Here's Why

Lowe's stock is lower Tuesday as Wall Street weighs a beat-and-raise quarter against declining revenue. This is what you need to know.

Kiplinger

CVS Stock Falls After Karen Lynch Ouster: What to Know

CVS stock is lower Friday after the embattled healthcare company said Karen Lynch is out as CEO, effective immediately

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.